CrossRef PrevotellaDerived Butyrate Inhibits CD8+ TCell Glycolysis via AKT/mTOR Signalling to Alleviate MASH Feixiang Xiong, Fengna Yan, Yuyong Jiang, Xiaomin Ji, Tong Wu, Yang Zhou, Xuejie Zhang, Dandan Chen, Yixin Hou Liver International .2026;[Epub] CrossRef CT-assessed abdominal visceral adiposity and MASLD: a sex-stratified cross-sectional analysis Linying Xu, Ting Chen, Yitian Xie, Xueyu Xiang, Yupeng Liu, Chongyong Xu, Shuran Wang Frontiers in Nutrition .2026;[Epub] CrossRef MetALD at the crossroads of metabolic and alcohol-related liver disease Gustavo Ayares, Luis Antonio Daz, Juan Pablo Arab, Marco Arrese Trends in Endocrinology & Metabolism .2026;[Epub] CrossRef Placebo-associated changes in MRI-PDFF and metabolic parameters in MASLD patients from phase Ib/IIa clinical trials: implications for early-phase trial design and translational endpoint interpretation Mengdi Lu, Hong Zhang, Xiaoxue Zhu, Jia Xu, Lin Xiang, Yue Hu, Jixuan Sun, Jiajia Mai, Yanhua Ding Frontiers in Pharmacology .2026;[Epub] CrossRef Aging-related skeletal muscle loss on the incidence of chronic kidney disease in patients with metabolic dysfunction-associated steatotic liver disease Aryoung Kim, Danbee Kang, Sung Chul Choi, Dong Hyun Sinn, Hye Ryoun Jang, Geum-Youn Gwak The Journal of nutrition, health and aging .2026

that is, these drugs were administered 1 week before NTG injection
They will work with you to monitor your progress, adjust your plan as needed, and provide the support system you need to succeed
Naturellement produit par nos cellules, il joue un rle central dans la protection contre le stress oxydatif, la dtoxification du foie et le soutien du systme immunitaire
Debes Current Hepatology Reports .2026;[Epub] CrossRef Survival benefits of nonsurgical triple therapy in hepatocellular carcinoma with inferior vena cava/right atrial tumor thrombus: A retrospective analysis from a multidisciplinary team Peng Tang, Jin Li, Jiayu Duan, Xin Wang, Jin Zhou, Yu Yang, Yong Zeng Oncology Letters .2026